Retatrutide 30mg
A$250.00
Retatrutide is recognized as one of the most promising new compounds for weight management and metabolic wellness. Unlike existing GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) or dual agonists like tirzepatide (Mounjaro, Zepbound), Retatrutide operates as a triple agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. This distinct mechanism has demonstrated impressive results in preliminary clinical trials, with participants experiencing a weight reduction exceeding 24% within less than a year at the highest researched doses.
In contrast to earlier metabolic medications that engage only a single hormonal pathway, retatrutide belongs to a newer class of treatments identified as triple agonists, which means it activates three metabolic hormone receptors concurrently:
→ GLP-1 (glucagon-like peptide-1)
→ GIP (glucose-dependent insulinotropic polypeptide)
→ glucagon receptors
These hormones play a crucial role in regulating hunger, insulin signaling, and energy metabolism. By activating all three pathways in unison, retatrutide has the potential to yield more pronounced metabolic effects than traditional weight-loss medications that concentrate on solely one pathway.
Manufactured in a facility that complies with GMP and ISO 9001:2008 standards, and assured to achieve at least 99% purity; each batch is subjected to comprehensive analysis to guarantee its quality.
All batches are verified to be free from LPS.
Intended Use: This product is meant solely for research purposes and is limited to scientific research and education only.
This product is not classified as a drug, food, or cosmetic, and must not be misclassified, misused, or incorrectly labelled as any of these categories.
By continuing with your purchase, you acknowledge that this compound is an investigational material that is not approved for general medical or therapeutic use by any regulatory organization.
You accept full responsibility for the appropriate handling, storage, and application of this product in compliance with all applicable laws and regulations.
No claims are made regarding safety, efficacy, or intended use outside of a controlled research environment.